Breast Carcinoma Profile I

50+ booked in last 3 days

No special precautions

Sample Type

Blood

Recommended for

Male, Female

Report

Within 24 Hours

Blood test at Home

NABL & CAP Accredited Labs

Accurate & Quality Test Reports

Trusted by Leading Doctors & Hospitals

Overview

The "Breast Carcinoma Profile I" test is performed on a breast lumpectomy specimen to assess certain important markers in breast cancer, including Estrogen Receptor (ER), Progesterone Receptor (PR), and Human Epidermal Growth Factor Receptor 2 (HER2/neu). The test involves immunohistochemistry (IHC) staining for ER, PR, and HER2/neu. If the HER2/neu test result is equivocal or borderline, it is reflexed to a fluorescence in situ hybridization (FISH) test for further evaluation. These markers play a crucial role in determining the molecular subtype of breast cancer and help guide treatment decisions. ER and PR status indicate whether the cancer is hormone receptor-positive or hormone receptor-negative, which is essential in choosing hormonal therapies. HER2/neu status is crucial for selecting targeted therapies that specifically inhibit the HER2 protein, which is overexpressed in some breast cancers. The results of this profile provide valuable information to oncologists in tailoring the most appropriate treatment plan for patients with breast carcinoma.

Breast Carcinoma Profile I Price

Metropolis Healthcare is a leading diagnostics centre and pathology lab in India equipped with the latest state-of-the-art technologies that provides the Breast Carcinoma Profile I with a clear pricing structure.

The Breast Carcinoma Profile I Price in Mumbai is ₹ 9,540 .

We are committed to deliver accurate and quality results from the best labs in India with complete transparency regarding test cost and turnaround time. No matter where you are, we strive to offer patients high-quality service that is affordable and accessible.

Frequently Asked Questions

What does Breast Carcinoma Profile I measure?

Breast Carcinoma Profile I measures various markers in breast tissue, including Estrogen Receptor (ER), Progesterone Receptor (PR), and Human Epidermal Growth Factor Receptor 2 (HER2/neu).

Why is Breast Carcinoma Profile I done?

• To diagnose breast cancer accurately • To determine the subtype of breast cancer for appropriate treatment planning • To evaluate the risk of recurrence or metastasis • To assess the need for targeted therapies, such as HER2-targeted treatment

When is Breast Carcinoma Profile I recommended and who should take the test?

Breast Carcinoma Profile I is recommended for • patients who have undergone breast lumpectomy, to understand the nature and characteristics of the tumour, or • patients with suspected or confirmed breast cancer.

What if the results of Breast Carcinoma Profile I are abnormal?

An abnormal result from Breast Carcinoma Profile I may indicate various conditions, including • presence of breast cancer, • specific subtype classification of breast cancer, or • overexpression or amplification of HER2 neu gene.

What to expect during Breast Carcinoma Profile I?

A breast lumpectomy specimen is collected during surgery. The specimen is sent to the laboratory for histopathological examination and various tests.

What preparations are required before Breast Carcinoma Profile I?

• Provide relevant clinical and radiological details to assist in the accurate interpretation of the results. • Inform your doctor if you have any specific requirements.

What other tests may be ordered with Breast Carcinoma Profile I?

• Estrogen receptor (ER) and progesterone receptor (PR) testing to determine hormone receptor status • Additional molecular tests or imaging studies, as per the healthcare provider's recommendation

What is Breast Carcinoma Profile I also known as?

Breast cancer panel or comprehensive breast cancer profile

What is breast carcinoma?

Breast carcinoma refers to cancer that originates in the breast tissue. It is the most common type of cancer among women worldwide. Early detection and accurate diagnosis play a crucial role in the management and treatment of breast carcinoma.

Ratings & Reviews (0)

No reviews available

Why Metropolis?

Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.

We offer a comprehensive range of 4000+ clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.